Cargando…

Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system

The incidence of central nervous system (CNS) diseases is increasing with the aging population. However, it remains challenging to deliver drugs into the CNS because of the existence of a blood–brain barrier (BBB). Notably, rabies virus glycoprotein (RVG) peptides have been developed as delivery lig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qinghua, Cheng, Shang, Qin, Fen, Fu, Ailing, Fu, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695342/ https://www.ncbi.nlm.nih.gov/pubmed/35423368 http://dx.doi.org/10.1039/d1ra00550b

Ejemplares similares

RVG Peptide-Functionalized Favipiravir Nanoparticle Delivery System Facilitates Antiviral Therapy of Neurotropic Virus Infection in a Mouse Model
por: Ren, Meishen, et al.
Publicado: (2023)

Cre Fused with RVG Peptide Mediates Targeted Genome Editing in Mouse Brain Cells In Vivo
por: Zou, Zhiyuan, et al.
Publicado: (2016)

Delivery of Therapeutic Agents to the Central Nervous System and the Promise of Extracellular Vesicles
por: René, Charlotte A., et al.
Publicado: (2021)

RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery
por: Hao, Rubin, et al.
Publicado: (2020)

Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis
por: Zhou, Ruiyi, et al.
Publicado: (2022)

Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
por: Zou, Li-Li, et al.
Publicado: (2013)

RVG-functionalized reduction sensitive micelles for the effective accumulation of doxorubicin in brain
por: Xu, Jiangkang, et al.
Publicado: (2021)

Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice
por: Han, Yang, et al.
Publicado: (2020)

Enhanced transport of plant‐produced rabies single‐chain antibody‐RVG peptide fusion protein across an in cellulo blood–brain barrier device
por: Phoolcharoen, Waranyoo, et al.
Publicado: (2017)

VHHs as tools for therapeutic protein delivery to the central nervous system
por: Wouters, Yessica, et al.
Publicado: (2022)

Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles
por: Chung, Eugene P., et al.
Publicado: (2020)

Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach
por: Pavan, Barbara, et al.
Publicado: (2008)

Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability
por: Zhang, Qun-Lin, et al.
Publicado: (2017)

Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2009)

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
por: Pandey, Manisha, et al.
Publicado: (2022)

Peptide nano ‘bead-grafting’ for SDT-facilitated immune checkpoints blocking
por: Zhang, Limin, et al.
Publicado: (2022)

Nanolipoprotein particles for co-delivery of cystine-knot peptides and Fab–based therapeutics
por: Darwish, Martine, et al.
Publicado: (2021)

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
por: Hanson, Leah R, et al.
Publicado: (2008)

Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders
por: Panzarini, Elisa, et al.
Publicado: (2020)

Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides
por: Nhàn, Nguyễn Thị Thanh, et al.
Publicado: (2023)

Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model
por: Wu, Hao, et al.
Publicado: (2022)

Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG(29) and Pluronic(®) P85 unimers
por: Hong, Wei, et al.
Publicado: (2018)

A dual-responsive nanocapsule via disulfide-induced self-assembly for therapeutic agent delivery
por: Lin, Wenhai, et al.
Publicado: (2016)

Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system
por: McGowan, Jeremy WD, et al.
Publicado: (2016)

Constraining the conformation of peptides with Au nanorods to construct multifunctional therapeutic agents with targeting, imaging, and photothermal abilities
por: Xie, Linlin, et al.
Publicado: (2018)

Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex
por: Xin, Xin, et al.
Publicado: (2021)

Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model [Corrigendum]
Publicado: (2023)

Nanochemistry of Protein-Based Delivery Agents
por: Rajendran, Subin R. C. K., et al.
Publicado: (2016)

Bedaquiline has potential for targeting tuberculosis reservoirs in the central nervous system
por: Pamreddy, Annapurna, et al.
Publicado: (2018)

In vivo peptide-based delivery of a gene-modifying enzyme into cells of the central nervous system
por: Allen, Jason K., et al.
Publicado: (2022)

Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review
por: Won, Seoyeon, et al.
Publicado: (2023)

Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders
por: Liu, Lu, et al.
Publicado: (2021)

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics
por: Kamma, Emily, et al.
Publicado: (2022)

Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice.
por: Wen, Jing, et al.
Publicado: (2019)

Nanomaterials for Drug Delivery to the Central Nervous System
por: Teleanu, Daniel Mihai, et al.
Publicado: (2019)

A Flavonoid on the Brain: Quercetin as a Potential Therapeutic Agent in Central Nervous System Disorders
por: Wróbel-Biedrawa, Dagmara, et al.
Publicado: (2022)

Immunomodulation induced by central nervous system‐related peptides as a therapeutic strategy for neurodegenerative disorders
por: Palumbo, María Laura, et al.
Publicado: (2021)

A self-indicating and antibacterial gelatine–chitosan blended hydrogel enabling real-time quality control and sustained bioactive agent delivery
por: Lai, Wing-Fu, et al.
Publicado: (2023)

Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases
por: Tomitaka, Asahi, et al.
Publicado: (2023)

Peptide therapeutics in the management of metastatic cancers
por: Bose, Debopriya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hm47tcjpu29jdql1ev9i4p2ep4